about
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly P...
Read More
2.28
0.07
(3.17%)
986.5K
XNAS Volume
XNAS 15 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Pyxis Oncology Inc is on 20 May 2026 for the purpose of Stifel Virtual Oncology
See details
Not Eligible
Expensive Valuation
Technically Neutral
Pyxis Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..